cytidylyl-3',5'-adenosine has been researched along with adenosine-5'-(n-ethylcarboxamide) in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hourani, SM; Payne, SL; Prentice, DJ | 1 |
| Bruijnzeel, PL; Groen, B; Moor, E; van Helden, HP; Westerink, BH | 1 |
| Khoyi, MA; Moloney, S; Smith, AD; Westfall, DP | 1 |
| Dubey, RK; Gillespie, DG; Jackson, EK; Shue, H | 1 |
4 other study(ies) available for cytidylyl-3',5'-adenosine and adenosine-5'-(n-ethylcarboxamide)
| Article | Year |
|---|---|
Activation of two sites by adenosine receptor agonists to cause relaxation in rat isolated mesenteric artery.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Anti-Arrhythmia Agents; Dinucleoside Phosphates; Dose-Response Relationship, Drug; Male; Mesenteric Arteries; Purinergic P1 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Theophylline; Triazines; Triazoles; Vasodilation; Vasodilator Agents | 1997 |
New generic approach to the treatment of organophosphate poisoning: adenosine receptor mediated inhibition of ACh-release.
Topics: Adenosine-5'-(N-ethylcarboxamide); Animals; Brain Chemistry; Cholinesterase Inhibitors; Dinucleoside Phosphates; Injections, Intramuscular; Injections, Subcutaneous; Poisoning; Purinergic P1 Receptor Agonists; Rats; Soman; Survival Rate; Time Factors | 1998 |
Species-dependent effects of adenosine receptor agonists on contractile responses of vas deferens to ATP.
Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cricetinae; Dinucleoside Phosphates; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Neuromuscular Junction; Phenethylamines; Purinergic P1 Receptor Agonists; Rabbits; Receptors, Purinergic P1; Species Specificity; Vas Deferens | 1999 |
A(2B) receptors mediate antimitogenesis in vascular smooth muscle cells.
Topics: 2-Chloroadenosine; Adenine; Adenosine; Adenosine Kinase; Adenosine-5'-(N-ethylcarboxamide); Animals; Anticoagulants; Antihypertensive Agents; Aorta, Abdominal; Becaplermin; Cell Division; Dinucleoside Phosphates; Enzyme Inhibitors; Hyperplasia; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Oligonucleotides, Antisense; Phenethylamines; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-sis; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Thymidine; Tritium; Tubercidin; Vasodilator Agents; Xanthines | 2000 |